Res. Asst. HÜLYA TEZEL YALÇIN | AVESİS

Research Information System

Publications & Works

Publication Network

Articles 13

1. **Gibberellic acid induced oxidative stress, mitochondrial division/fusion imbalance, and autophagy in the ovary of Carassius auratus Reply**

Yalcin H., Çakır D. A., Yirün A., Sanajou ., Isik G., Bozdemir O., et al.

TOXICOLOGY RESEARCH , vol.14, no.5, 2025 (SCI-Expanded, Scopus)

2. Drug safety signals in breastfeeding: Bridging evidence from European and US pharmacovigilance systems

Yalcin H., YALÇIN N., Ceulemans M., Allegaert K.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , 2025 (SCI-Expanded, Scopus)

3. Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS): Tiny Tummies, Key Decisions.

Tezel Yalçın H., Yalçın N., Allegaert K.

Pharmaceuticals (Basel, Switzerland) , vol.18, no.5, 2025 (SCI-Expanded, Scopus)

4. Comparative in vitro and in silico evaluation of the toxic effects of metformin and/or ascorbic acid, new treatment options in the treatment of Melasma

Yalcin H., ÇAKIR D. A., YİRÜN A., Sanajou S., Isik G., Bozdemir O., et al.

TOXICOLOGY RESEARCH , vol.14, no.1, 2025 (SCI-Expanded, Scopus) Sustainable Development

Sustainable Development

5. Drug Safety During Breastfeeding: A Comparative Analysis of FDA Adverse Event Reports and LactMed®

Yalcin H., YALÇIN N., Ceulemans M., Allegaert K.

PHARMACEUTICALS , vol.17, no.12, 2024 (SCI-Expanded, Scopus)

6. Synthesis and characterization of new hexahydroquinoline derivatives and evaluation of their cytotoxicity, intracellular ROS production, and inhibitory effects on inflammatory mediators

Pehlivanlar E., Cakir D. A., Sanajou S., Yalcin H. T., Baydar T., Erkekoglu P., et al.

TURKISH JOURNAL OF CHEMISTRY , vol.48, no.4, pp.659-675, 2024 (SCI-Expanded, Scopus, TRDizin)

7. Toxicity of serotonin-norepinephrine reuptake inhibitors (SNRIs) during pregnancy and lactation

Canitez G., ŞİMŞEK R., ÇAKIR D. A., Yalcin H., BAYDAR T., ERKEKOĞLU Ü. P.

ISTANBUL JOURNAL OF PHARMACY , no.2, pp.255-267, 2024 (ESCI, TRDizin)

8. Cıva Maruziyetinin Nörodejeneratif Hastalıklar Üzerindeki Etkisi

Duru E., Tezel Yalçın H., Çakır D. A., Baydar T., Erkekoğlu Ü. P.

Hacettepe University Journal of the Faculty of Pharmacy , vol.44, no.1, pp.62-74, 2024 (Scopus)

Creative Commons License

9. Alzheimer's Disease In Vivo Models: A Traditional Review

Tütüncü S., Tezel H., Balcı Özyurt A., Yirün A., Baydar T., Erkekoğlu Ü. P.

Literatür Eczacılık Bilimleri Dergisi , vol.12, pp.8-19, 2023 (TRDizin)

10. Dental Implants and Implant Coatings: A Focus on Their Toxicity and Safety

Özkan A., Çakır D. A., Tezel H., Sanajou S., Yirün A., Baydar T., et al.

JOURNAL OF ENVIRONMENTAL PATHOLOGY, TOXICOLOGY AND ONCOLOGY , vol.42, no.2, pp.31-48, 2023 (SCI-Expanded, Scopus)

11. Biyosensörler ve Kullanım Alanları-Geleneksel Derleme

Özer İ., Tezer H., Sanajou S., Yirün A., BAYDAR T., ERKEKOĞLU Ü. P.

Literatür Eczacılık Bilimleri Dergisi , vol.22, no.1, pp.35-48, 2022 (TRDizin)

12. Current Approaches For Melasma Treatment and Possible Toxic Effects Melazma Tedavisinde Güncel Yaklaşımlar ve Olası Toksik Etkileri

Tezel H., Balci Özyurt A., ERKEKOĞLU Ü. P.

Hacettepe University Journal of the Faculty of Pharmacy , vol.42, no.2, pp.105-120, 2022 (Scopus)

Creative Commons License

Sustainable Development

13. Recent Methods Used in the Determination of Ocular Toxicity of Drugs and Chemicals

Tezel H., Sabuncuoğlu S., Erkekoğlu Ü. P.

Literatür Eczacılık Bilimleri Dergisi , vol.10, pp.65-75, 2021 (TRDizin)

Papers Presented at Peer-Reviewed Scientific Conferences 1

1. The Protective Effects of Polygala Species on Lipopolysaccaride-Induced Neurotoxicity

Işık G., ÖZENVER N., UĞURLU AYDIN Z., DÖNMEZ A. A., TEZEL H., ERKEKOĞLU Ü. P., et al.

PSE Meeting 2023: PSE Natural Drug Discovery- Current Approach and Future Perspectives, Turkey, 12 - 15 October 2023, (Summary Text)